Candriam SCA’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Candriam SCA’s Portfolio MOR Stock Details MOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-58,169	Closed	-$212K	–	887
2023 Q1	$212K	Hold	58,169	–	–	﹤0.01%	868
2022 Q4	$208K	Hold	58,169	–	–	﹤0.01%	853
2022 Q3	$292K	Hold	58,169	–	–	﹤0.01%	853
2022 Q2	$281K	Sell	58,169 -210,666	-78%	-$1.16M	﹤0.01%	762
2022 Q1	$1.82M	Hold	268,835	–	–	0.01%	562
2021 Q4	$7.71M	Hold	268,835	–	–	0.05%	297
2021 Q3	$3.16M	Hold	268,835	–	–	0.02%	485
2021 Q2	$5.17M	Sell	268,835 -12,646	-4%	-$271K	0.04%	401
2021 Q1	$7.66M	Sell	281,481 -5	-0%	-$134	0.06%	300
2020 Q4	$7.98M	Sell	281,486 -22,196	-7%	-$608K	0.06%	308
2020 Q3	$9.53M	Buy	303,682 +36,932	+14%	+$1.2M	0.09%	246
2020 Q2	$8.45M	Buy	266,750 +159,044	+148%	+$4.64M	0.09%	242
2020 Q1	$3.75M	Buy	107,706 +85	+0.1%	+$2.5K	0.04%	419
2019 Q4	$3.84M	Buy	+107,621	New	+$3.21M	0.04%	433

Other funds holding MOR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Candriam SCA's MOR Position: Q2 2023 in Review

Candriam SCA sold out of MorphoSys AG American Depositary Shares (MOR) in Q2 2023, closing a stake of 58,169 shares — an estimated $212K sold.

Candriam SCA first reported a position in MOR in Q4 2019 and held it in 14 quarters. The position peaked at $9.53M in Q3 2020. 39 funds tracked by Wall St. Rank hold MOR as of Q2 2023.

Candriam SCA reported no remaining MorphoSys AG American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Candriam SCA sold 58,169 MorphoSys AG American Depositary Shares shares in Q2 2023, an estimated $212K.
Candriam SCA first reported a position in MorphoSys AG American Depositary Shares in Q4 2019 and held it in 14 quarters.
Candriam SCA's MorphoSys AG American Depositary Shares position peaked at $9.53M in Q3 2020.
39 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q2 2023.

Based on Candriam SCA's 13F filing for Q2 2023, filed 8 Aug 2023.